Trials / Withdrawn
WithdrawnNCT04001998
Healthy Volunteer Study Comparing Tablet and Capsule Formulations
A Two-Part, Open Label, Complete Crossover Study to Compare the Tablet and Capsule Formulations of BLD-2660, Including a Food Effect Assessment of the Tablet Formulation, and to Assess Dose Proportionality Following Single Oral Doses of BLD-2660 in Tablet Formulation
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Blade Therapeutics · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Single center, randomized, open label, two-part crossover study designed to evaluate the PK, food effect, dose proportionality, safety, and tolerability of BLD-2660 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLD-2660 | Randomized to active product |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2021-06-01
- Completion
- 2021-07-01
- First posted
- 2019-06-28
- Last updated
- 2020-10-30
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT04001998. Inclusion in this directory is not an endorsement.